Imidazole → 13,13,14,14-Tetramethyl-3,6,9,12-tetraoxa-13-silapentadecan-1-ol

HRID 1255966Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 1255966
[C:1]([Si:5]([CH3:14])([CH3:13])[O:6][CH2:7][CH2:8][O:9][CH:10](O)[CH3:11])([CH3:4])([CH3:3])[CH3:2].[CH2:15]([OH:27])[CH2:16][O:17][CH2:18][CH2:19][O:20]CCOCCO.CC([Si](Cl)(C)C)(C)C.N1C=CN=C1>CN(C=O)C>[C:1]([Si:5]([CH3:14])([CH3:13])[O:6][CH2:7][CH2:8][O:9][CH2:10][CH2:11][O:27][CH2:15][CH2:16][O:17][CH2:18][CH2:19][OH:20])([CH3:4])([CH3:3])[CH3:2]

Komponenten

6

Edukt 4

HCID 795ImidazoleHCID 8200Tetraethylene GlycolHCID 28928tert-Butyldimethylsilyl chlorideHCID 866188412-(tert-Butyl-dimethyl-silanyloxy)-ethoxyl-ethanol

Produkt 1

HCID 1482766913,13,14,14-Tetramethyl-3,6,9,12-tetraoxa-13-silapentadecan-1-ol

Reagenzien, Katalysatoren, Lösungsmittel 1

HCID 6228DimethylformamideLösungsmittel

Versuchsvorschrift

Compound 28b was prepared according to the procedure described hereinabove for Compound 28a, using tetraethylene glycol (6 grams, 30 mmol), TBDMSCl (3 grams, 20 mmol), and imidazole (1.4 grams, 20 mmol) in DMF (24 ml), yielding 3.79 grams of the product (41% yield).

Quellen und Nachweise

ORD-Eintrag
ord-0c06a23abbe544bf87e80226b614379a
Quelldatensatz
uspto-grants-2013_06
Patentnummer
US08461166B2

Notizen zur Reaktion

Wird geladen…